| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Easom Eric | Chief Executive Officer, Director | C/O AN2 THERAPEUTICS, INC., 1800 EL CAMINO REAL, SUITE D, MENLO PARK | /s/ Lucy Day, Attorney-in-Fact for Eric Easom | 2025-06-03 | 0001914503 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANTX | Common Stock | Purchase | $10.7K | +10K | +4.06% | $1.07 | 256K | Jun 2, 2025 | Direct | F1, F2 |
| holding | ANTX | Common Stock | 1.07M | Jun 2, 2025 | See Footnote | F3 | |||||
| holding | ANTX | Common Stock | 97.1K | Jun 2, 2025 | See Footnote | F4 | |||||
| holding | ANTX | Common Stock | 97.1K | Jun 2, 2025 | See Footnote | F5 |
| Id | Content |
|---|---|
| F1 | This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.05 to $1.0699 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. |
| F2 | Includes (i) 145,250 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date and (ii) a balance of 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date. |
| F3 | Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019. |
| F4 | Consists of shares of Common Stock held by the C. Easom Irrevocable Trust dated October 8, 2021. |
| F5 | Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021. |